The U.S. FDA has set February 14, 2025, as the action date for a GSK MenABCWY combination vaccine candidate that protects against the five most common groups of bacteria causing invasive meningococcal disease. GSK’s 5-in-1 MenABCWY... READ →
Precision Vaccinations
/ April 16th, 2024Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.
